Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06504394
Title A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NZL | ESP

Facility Status City State Zip Country Details
Clinical Research Alliance ( Site 0101) RECRUITING Westbury New York 11590 United States Details
IC La Serena Research ( Site 0204) RECRUITING La Serena. Coquimbo 1720430 Chile Details
Clínica Inmunocel ( Site 0201) RECRUITING Santiago Region M. De Santiago 7580206 Chile Details
Auckland City Hospital ( Site 1001) RECRUITING Auckland 1023 New Zealand Details
Pratia MCM Krakow ( Site 0503) RECRUITING Krakow Malopolskie 30-727 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site RECRUITING Warszawa Mazowieckie 02-781 Poland Details
Hospital Universitario de Salamanca ( Site 0702) RECRUITING Salamanca Castilla Y Leon 37007 Spain Details
Hospital Universitario 12 de Octubre-Hemathology and hemotherapy ( Site 0701) RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field